Amneal Pharmaceuticals, Inc. - COM STK CL A (AMRX)

Q2 2023 13F Holders as of 6/30/2023

Type / Class
Equity / COM STK CL A
Number of holders
122
Total Shares
97.4M
Shares change
+667K
Total reported value, excl. options
$302M
Value change
+$4.22M
Put/Call ratio
0.38
Number of buys
57
Number of sells
-63
Price
$3.10
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.